The interesting stuff starts at around page 15. A couple interesting things: - Seems Shire or BMRN [I think the later] were likely interested (very early) but likely got way too expensive for them. - They did try to sell the company before data and after EU approval but nothing developed to offer though Roche did have draft merger agreement at one point. - First Roche offer was 7/26 at $70/share - 8/1 received offer from another company at $57/share
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.